FASN and breast carcinoma: Inhibition of FASN promotes an increase in the NADPH/NADP+ ratio in breast cancer cells; the redox imbalance leads to the activation of stress-related proapoptotic kinases such as JNK and p38 MAPK as well as energy-sensing AMP-activated protein kinase (AMPK) (Schroeder et al. 2021).